tirzepatide) Written by: Thomas Kolbe-Booysen , 27 Apr 2026 16 min read Reviewed and fact-checked: Ayesha Bashir , Prescribing Pharmacist, 27 Apr 2026 Mounjaro (tirzepatide) and Wegovy (semaglutide) are weekly weight loss injections that can help you reach a healthier weight
These products tend to have downward pressure on price over time, and we're obviously seeing that. Lifetime Benefits vs Cost Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, was approved for weight management in 2023, while semaglutide, a GLP-1 receptor agonist, was approved 2 years earlier
Exposure of live filaments to high or low temperatures (50 C or 4 C) or incubation with 200 mM DTT 70 were among the most reproducible treatments to induce limited cell lysis
Most Common Side Effects Nausea: The most frequently reported side effect, affecting about 44% of patients in clinical trials